| It just means that when entity A wants to buy entity B, they have a general 'cost of capital they use to determine whether or not they want to buy something - and it doesn't matter if it's with cash or debt really. If you're an employee worrying about stuff, well, I wouldn't unless you're the CEO and have the power to make huge investments ... If you are a very profitable company, i.e. 'cash cow' without a lot of debt, then private equity may be interested in buying your company with heavy borrowing, using the profits to pay for the debt. Another way to look at it is, the company is not taking enough risk given the price of cash available in the market. One thing a company might want to do is take on debt and extend the business. If it's a private company with strong board control, and the shareholders don't want to sell, well, then you don't have to worry. As for companies that do get acquired, this notion that PE just wants to screw things up short term etc. is a bit bullshit. Burger King was acquired by that famous Brazilian outfit, and they turned the company around. In that case, probably some execs got fired to clear the path for the new vision, but it will vary case by case. The company might get split up into components. Maybe there is a garbage part of the company dragging on revenues. Maybe that supposedly crappy part of the company is actually more 'long term' and killing R&D would hurt the company, but that's surprisingly hard to establish. A lot of R&D is a waste. With rising interest rates, debt becomes more expensive, and companies have less to worry about getting bought out like this - of course, companies that are carrying debt have a greater burden. In summary, companies probably need to adjust a bit given interest rates. This is where a good CFO comes in. |
If its speculative, then its either going to deliver a multiple of its investment, or just be a cost, but one that may be worth it to explore an opportunity. I doubt that R&D which proves no viable product is feasible, or no market exists, is more wasteful than allowing a business to wither on aging uncompetitive product lines for want of proper R&D.